- Reagents and Kits
- Instruments
- Software and Services
Breast Cancer Screening Market size was valued at USD 4,287.3 million in 2023 and is poised to grow at a CAGR of 6.8% from 2024 to 2030. Breast cancer is one of the most commonly occurring cancers among the women population across the globe. The key factors driving the breast cancer screening market are technological advancements in screening technologies such as digital mammography, increasing prevalence of breast cancer worldwide, and government screening programs for breast cancer diagnosis are anticipated to drive the market over the forecast period. Additionally, Factors responsible for the growth of the breast cancer screening market include the rising awareness about the early detection of breast cancer and the increasing incidence of breast cancer. For instance, according to American Cancer Society estimations, more than 310,000 cases of invasive breast cancer cases will be diagnosed in 2024. In the meantime, there is an increasing necessity for breast cancer screening tests in the developing and developed nations.
Furthermore, the rising R&D expenditure by the key players and the development of innovative strategies are predicted to drive market growth through the forecast period. For instance, in March 2022, LifeCell Inaugurated Breast Screen Panel, a comprehensive genetic screening test assessing women's danger of breast cancer. Such innovative testing methods lead to augmented adoption of breast cancer screening, driving the market growth. However, the high cost associated with breast cancer screening equipment, pain during the procedure, and radiation exposure from the mammography test remain substantial barriers that hamper the growth of the breast cancer screening market in the forecast period. However, the key opportunities associated with the breast cancer screening market are the rising government initiatives and support. Early detection of breast cancer can lead to sought-after outcomes, including augmented survival rate, many treatment options, and improved quality of life.
Breast Cancer Screening Market Key Developments:
- In March 2022, Life Cell Inaugurated Breast Screen Panel, an inclusive genetic screening test that measures the risk of breast cancer in women.
Breast Cancer Screening Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.8%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Breast Cancer Screening Market Dynamics
The increasing prevalence of tumors especially in women in developed and emerging countries is a key factor surge in the Breast Cancer Screening market over the forecast years. Rising accessibility and affordability of screening technologies, especially in emerging economies and underserved regions, subsidized the breast cancer screening market growth. Additionally, the aging population aged 55 and above is having risk prone to breast cancer, and also advancements in personalized medicines such as genetic testing, and risk assessment tools are anticipated to drive the breast cancer screening market and aid in the development of targeted screening tactics for patients at high risk of breast cancer. For instance, In May 2022, VolparaHealth presented updated products for its unified platform to deliver custom-made breast care at the SBI/ACR Breast Imaging Symposium 2022. Volpara's AI-driven breast software tools recover mammography quality and reporting, volumetric breast density measurements, and cancer risk assessment. These kind of developments by market players aids in speeding up breast cancer screening market growth in the forecast period.
Breast Cancer Screening Market Segmentation
By Component
By Technology
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
By Application
- Screening
- Diagnostic and Predictive
- Prognostic
- Research
By End Use
- Hospitals and Clinics
- Diagnostic Centres
- Academic and Research Institutes
- Others
Frequently Asked Questions
The Breast Cancer Screening market size is expanded to be valued at USD 4,287.3 million.
North America is expected to dominate the Breast Cancer Screening market.
General Electric Company, Siemens Healthineers AG, BD, Danaher, Hoffmann-La Roche Ltd., Hologic Inc., Koninklijke Philips N.V., Myriad Genetics, Oncocyte Corporation, QIAGEN, Syantra, Inc., Thermo Fisher Scientific Inc.
The key factors driving the breast cancer screening market are the increasing prevalence of breast cancers, additionally, early detection of breast cancer, and advancements in cancer screening technologies.
Historic years considered for the market study are 2019 through 2023, 2023 is considered as the base year for market estimation and ten years forecast presented from 2024– 2030.
Key Features of the Reports
- The breast cancer screening market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
- The report covers the in-detail insights about the competitor’s overview, company share analysis, key market developments and their key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report track recent innovations, key developments and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory frame work and reimbursement scenario.
| 1. Executive Summary |
| 2. Global Breast Cancer Screening Market Introduction |
| 2.1. Global Breast Cancer Screening Market Taxonomy |
| 2.2. Global Breast Cancer Screening Market Definitions |
| 2.2.1. Component |
| 2.2.2. Technology |
| 2.2.3. Application |
| 2.2.4. End User |
| 2.2.5. By Region |
| 3. Global Breast Cancer Screening Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Breast Cancer Screening Market Dynamic Factors - Impact Analysis |
| 3.6. Global Breast Cancer Screening Market Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Breast Cancer Screening Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Breast Cancer Screening Market, By Component, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. Reagents and Kits |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software and Services |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Breast Cancer Screening Market, By Technology, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1. Imaging |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Biopsy |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Genomic Tests |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Blood Tests |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Breast Cancer Screening Market, By Application, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1. Screening |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic and Predictive |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Prognostic |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Research |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Breast Cancer Screening Market, By End User, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. Hospitals and Clinics |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Centers |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Academic and Research Institutes |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Breast Cancer Screening Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Region, 2024-2030 |
| 10. North America Breast Cancer Screening Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 10.1. Component Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Reagents and Kits |
| 10.1.2. Instruments |
| 10.1.3. Software and Services |
| 10.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Imaging |
| 10.2.2. Biopsy |
| 10.2.3. Genomic Tests |
| 10.2.4. Blood Tests |
| 10.2.5. Others |
| 10.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Screening |
| 10.3.2. Diagnostic and Predictive |
| 10.3.3. Prognostic |
| 10.3.4. Research |
| 10.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospitals and Clinics |
| 10.4.2. Diagnostic Centers |
| 10.4.3. Academic and Reaserach Institutes |
| 10.4.4. Others |
| 10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2024-2030 |
| 10.7. North America Breast Cancer Screening Market Dynamics Trends |
| 11. Europe Breast Cancer Screening Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 11.1. Component Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Reagents and Kits |
| 11.1.2. Instruments |
| 11.1.3. Software and Services |
| 11.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Imaging |
| 11.2.2. Biopsy |
| 11.2.3. Genomic Tests |
| 11.2.4. Blood Tests |
| 11.2.5. Others |
| 11.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Screening |
| 11.3.2. Diagnostic and Predictive |
| 11.3.3. Prognostic |
| 11.3.4. Research |
| 11.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospitals and Clinics |
| 11.4.2. Diagnostic Centers |
| 11.4.3. Academic and Reaserach Institutes |
| 11.4.4. Others |
| 11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Rest of Europe |
| 11.6. Europe Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2024-2030 |
| 11.7. Europe Breast Cancer Screening Market Dynamics Trends |
| 12. Asia-Pacific Breast Cancer Screening Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 12.1. Component Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Reagents and Kits |
| 12.1.2. Instruments |
| 12.1.3. Software and Services |
| 12.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Imaging |
| 12.2.2. Biopsy |
| 12.2.3. Genomic Tests |
| 12.2.4. Blood Tests |
| 12.2.5. Others |
| 12.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Screening |
| 12.3.2. Diagnostic and Predictive |
| 12.3.3. Prognostic |
| 12.3.4. Research |
| 12.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospitals and Clinics |
| 12.4.2. Diagnostic Centers |
| 12.4.3. Academic and Reaserach Institutes |
| 12.4.4. Others |
| 12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2024-2030 |
| 12.7. Asia-Pacific Breast Cancer Screening Market Dynamics Trends |
| 13. Latin America Breast Cancer Screening Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 13.1. Component Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Reagents and Kits |
| 13.1.2. Instruments |
| 13.1.3. Software and Services |
| 13.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Imaging |
| 13.2.2. Biopsy |
| 13.2.3. Genomic Tests |
| 13.2.4. Blood Tests |
| 13.2.5. Others |
| 13.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Screening |
| 13.3.2. Diagnostic and Predictive |
| 13.3.3. Prognostic |
| 13.3.4. Research |
| 13.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospitals and Clinics |
| 13.4.2. Diagnostic Centers |
| 13.4.3. Academic and Reaserach Institutes |
| 13.4.4. Others |
| 13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2024-2030 |
| 13.7. Latin America Breast Cancer Screening Market Dynamics Trends |
| 14. Middle East and Africa Breast Cancer Screening Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 14.1. Component Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Reagents and Kits |
| 14.1.2. Instruments |
| 14.1.3. Software and Services |
| 14.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Imaging |
| 14.2.2. Biopsy |
| 14.2.3. Genomic Tests |
| 14.2.4. Blood Tests |
| 14.2.5. Others |
| 14.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Screening |
| 14.3.2. Diagnostic and Predictive |
| 14.3.3. Prognostic |
| 14.3.4. Research |
| 14.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospitals and Clinics |
| 14.4.2. Diagnostic Centers |
| 14.4.3. Academic and Reaserach Institutes |
| 14.4.4. Others |
| 14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Breast Cancer Screening Market - Opportunity Analysis Index, By Component, By Technology, By Application, By End User, and Country, 2024-2030 |
| 14.7. MEA Breast Cancer Screening Market Dynamics Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. General Electric Company |
| 15.2.2. Siemens Healthineers AG |
| 15.2.3. BD |
| 15.2.4. Danaher |
| 15.2.5. F. Hoffmann-La Roche Ltd. |
| 15.2.6. Hologic Inc. |
| 15.2.7. Koninklijke Philips N.V. |
| 15.2.8. Myriad Genetics |
| 15.2.9. Oncocyte Corporation |
| 15.2.10. QIAGEN |
| 15.2.11. Syantra, Inc. |
| 15.2.12. Thermo Fisher Scientific Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- General Electric Company
- Siemens Healthineers AG
- BD
- Danaher
- Hoffmann-La Roche Ltd.
- Hologic Inc.
- Koninklijke Philips N.V.
- Myriad Genetics
- Oncocyte Corporation
- QIAGEN
- Syantra, Inc.
- Thermo Fisher Scientific Inc.